Anti-metastasis via down-regulation of ROS (reactive oxygen species) and PI3/Akt/mTOR in lung cancer cells [9], and CuB via downregulation of the pFAK pathway in breast cancer [92]. This evidence concerns the gene AKT1 and lung carcinoma.